Contact Information
Company Information
Company
Iovance Biotherapeutics, Inc.
Annual Revenue
164070000.0
Technologies
Amazon CloudFront
Salesforce
Route 53
Mimecast
ServiceNow
Amazon AWS
Microsoft Office 365
Mobile Friendly
Google Font API
New Relic
Vimeo
Google Tag Manager
Akamai RUM
Remote
AI
Keywords
immuno oncology
autologous cell therapy
tumor infiltrating lymphocytes
novel cancer immunotherapies
cell therapy
biotechnology: biological products (no diagnostic substances)
health care
biotechnology research
til therapy
t-cell therapy
personalized medicine
cancer treatment
immunotherapy
solid tumors
clinical trials
genetically modified til
pbl therapy
autologous therapy
advanced solid tumors
neoplasms
neoantigens
chronic lymphocytic leukemia
small lymphocytic lymphoma
melanoma
non-small cell lung cancer
gynecologic cancers
interleukin-2
lymphodepleting chemotherapy
tumor markers
patient-specific therapy
cell banking
cryopreservation
manufacturing process
good manufacturing practices
fda compliance
cancer vaccines
combination therapies
investigational agents
cell therapy center
cancer biomarkers
scientific publications
innovative therapies
biopharmaceutical industry
translational medicine
biological therapies
quality assurance
patient recruitment
drug development
clinical research
therapy deployment
immune response
detecting cancer
biomedical ethics
healthcare compliance
personalized therapy
therapeutic targets
therapy innovation
biopharmaceutical
tumor-infiltrating lymphocyte therapy
cervical cancer
gene-edited therapies
patient-centric innovation
oncology
healthcare providers
biopharmaceutical partnerships
investor engagement
precision immunotherapy
treatment-resistant cancers
patient support programs
commercial growth
regulatory approvals
innovative cancer therapies
therapeutic innovation
cancer patients
healthcare professionals
biotechnology sector
health
wellness & fitness
hospital & health care
Get Full Contact Details
Subscribe to reveal email addresses and export contacts.
View Plans